Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORα

被引:148
作者
Mamontova, A
Séguret-Macé, S
Esposito, B
Chaniale, C
Bouly, M
Delhaye-Bouchaud, N
Luc, G
Staels, B
Duverger, N
Mariani, J
Tedgui, A
机构
[1] INSERM U141, F-75475 Paris 10, France
[2] IFR Circulat Lariboisiere, F-75475 Paris 10, France
[3] Rhone Poulenc Rorer, Gencell Div, Atherosclerosis Dept, Ctr Rech Vitry Alfortville, Vitry Sur Seine, France
[4] Inst Gustave Roussy, Villejuif, France
[5] Inst Neurosci, Dev Neurobiol Lab, CNRS URA 1488, Paris, France
[6] Univ Paris 06, Paris, France
关键词
hypercholesterolemia; genes; cholesterol; apolipoproteins;
D O I
10.1161/01.CIR.98.24.2738
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Hypoalphalipoproteinemia is the most common lipoprotein abnormality in patients with coronary artery disease, yet its causes are unknown. Methods aad Results-We show that the homozygous staggerer (sg/sg) mutant mouse, which carries a deletion within the nuclear receptor ROR alpha gene, develops severe atherosclerosis when maintained on an atherogenic diet. In addition, sg/sg mice display a profound hypoalphalipoproteinemia, which is associated with decreased plasma levels of the major HDL proteins, apolipoprotein (apo) A-I and apoA-II. This decrease in HDL levels in sg/sg mice is due to lowered apoA-I gene expression in the intestine but not in the liver. ApoA-II gene expression is unaffected. Conclusions-These results suggest that the ROR alpha gene contributes to the plasma HDL level and susceptibility to atherosclerosis.
引用
收藏
页码:2738 / 2743
页数:6
相关论文
共 42 条
[1]   IDENTIFICATION OF NUCLEAR RECEPTOR MESSENGER-RNAS BY RT-PCR AMPLIFICATION OF CONSERVED ZINC-FINGER MOTIF SEQUENCES [J].
BECKERANDRE, M ;
ANDRE, E ;
DELAMARTER, JF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (03) :1371-1379
[2]  
BECKERANDRE M, 1994, J BIOL CHEM, V269, P28531
[3]   OPPOSITE IN-VITRO AND IN-VIVO REGULATION OF HEPATIC APOLIPOPROTEIN-A-I GENE-EXPRESSION BY RETINOIC ACID - ABSENCE OF EFFECTS ON APOLIPOPROTEIN A-II GENE-EXPRESSION [J].
BERTHOU, L ;
STAELS, B ;
SALDICCO, I ;
BERTHELOT, K ;
CASEY, J ;
FRUCHART, JC ;
DENEFLE, P ;
BRANELLEC, D .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10) :1657-1664
[4]   Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice [J].
Berthou, L ;
Duverger, N ;
Emmanuel, F ;
Langouet, S ;
Auwerx, J ;
Guillouzo, A ;
Fruchart, JC ;
Rubin, E ;
Denefle, P ;
Staels, B ;
Branellec, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2408-2416
[5]   METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS [J].
BILHEIMER, DW ;
LEVY, RI ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :212-+
[6]  
BRESLOW JL, 1989, METABOLIC BASIS INHE, V1, P1251
[7]   RZRS, A NEW FAMILY OF RETINOID-RELATED ORPHAN RECEPTORS THAT FUNCTION AS BOTH MONOMERS HOMODIMERS [J].
CARLBERG, C ;
VANHUIJSDUIJNEN, RH ;
STAPLE, JK ;
DELAMARTER, JF ;
BECKERANDRE, M .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (06) :757-770
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   GENETIC-BASIS OF LIPOPROTEIN DISORDERS [J].
DAMMERMAN, M ;
BRESLOW, JL .
CIRCULATION, 1995, 91 (02) :505-512
[10]   Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits [J].
Duverger, N ;
Kruth, H ;
Emmanuel, F ;
Caillaud, JM ;
Viglietta, C ;
Castro, G ;
Tailleux, A ;
Fievet, C ;
Fruchart, JC ;
Houdebine, LM ;
Denefle, P .
CIRCULATION, 1996, 94 (04) :713-717